19-11-2025 03:05 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Deliverable Volume
Mankind Pharma Ltd.
 
BSE Code 543904
ISIN Demat INE634S01028
Book Value 375.78
NSE Code MANKIND
Dividend Yield % 0.00
Market Cap 917995.52
P/E 54.95
EPS 40.47
Face Value 1  
Exchange : Period From : Period To :
DateTotal VolumeDeliverable VolumeDeliverable Volume [%]
18-Nov-2025 4336 3399 78.39
17-Nov-2025 4628 2357 50.93
14-Nov-2025 4918 2444 49.69
13-Nov-2025 1066137 1051518 98.63
12-Nov-2025 128600 123866 96.32
11-Nov-2025 6656 4554 68.42
10-Nov-2025 114120 108337 94.93
07-Nov-2025 80560 70781 87.86
06-Nov-2025 5259 2585 49.15
04-Nov-2025 98266 91936 93.56
03-Nov-2025 5190 2513 48.42
Page 1 of 1
Prev || Next
 

Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors

KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’

Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.